Cargando…
Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy
There has been significant progress in utilizing our immune system against cancer, mainly by checkpoint blockade and T cell-mediated therapies. The field of cancer immunotherapy is growing rapidly but durable clinical benefits occur only in a small subset of responding patients. It is currently reco...
Autores principales: | Le Bourgeois, Thibault, Strauss, Laura, Aksoylar, Halil-Ibrahim, Daneshmandi, Saeed, Seth, Pankaj, Patsoukis, Nikolaos, Boussiotis, Vassiliki A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085483/ https://www.ncbi.nlm.nih.gov/pubmed/30123774 http://dx.doi.org/10.3389/fonc.2018.00237 |
Ejemplares similares
-
T Cell Metabolism in Cancer Immunotherapy
por: Aksoylar, Halil-Ibrahim, et al.
Publicado: (2020) -
Publisher Correction: Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells
por: Bardhan, Kankana, et al.
Publicado: (2020) -
Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells
por: Bardhan, Kankana, et al.
Publicado: (2019) -
Immunometabolic Regulations Mediated by Coinhibitory Receptors and Their Impact on T Cell Immune Responses
por: Patsoukis, Nikolaos, et al.
Publicado: (2017) -
Clinical significance of T cell metabolic reprogramming in cancer
por: Herbel, Christoph, et al.
Publicado: (2016)